Friday 18 November 2011

Avastin Loses FDA Approval to Treat Breast Cancer

Original story here. Avastin has been shown to improve the quality of life for Stage 4 cancer patients, extending life by several months. FDA felt the additional several months of life wasn't enough justification for the treatment.Click

Read more ...

No comments:

Post a Comment